Target intelligence / Profile preview

DNA crosslinking and damage induction via platinum adduct (null)

Target
null
Molecular classification
Other
01

Overview

**DNA crosslinking and damage induction via platinum adduct** refers to the process by which platinum-based chemotherapeutic agents—most notably cisplatin, carboplatin, and oxaliplatin—form covalent bonds with nuclear DNA. These drugs create a variety of **DNA lesions**, including intrastrand and interstrand crosslinks as well as bulky monoadducts. The most common lesion is the intrastrand guanine–guanine crosslink (>70% for cisplatin), which distorts the double helix structure. These modifications block essential processes such as **DNA replication** and **transcription**, ultimately triggering cell cycle arrest or apoptosis if not repaired. Cells attempt to remove these lesions primarily through nucleotide excision repair (NER) pathways; proteins such as ERCC1 are critical for this process. Deficiencies or variations in these repair mechanisms can influence both drug sensitivity and resistance in tumors. Overexpression or increased activity of NER components is associated with clinical resistance to platinum drugs. While this mechanism is central to the antitumor efficacy of several widely used chemotherapies, it also underlies their dose-limiting toxicities—including nephrotoxicity, neurotoxicity, ototoxicity—and contributes significantly to acquired drug resistance during cancer treatment[2][4][6]. **Note:** This entry describes a *mechanism* rather than a discrete molecular target such as an enzyme or receptor; thus it does not fit standard definitions for "therapeutic target" classification. It represents a pharmacodynamic effect rather than a single protein/gene product[1].

Other names
Platinum-DNA adduct formationPlatinum-induced DNA crosslinkingCisplatin-DNA adductsPlatinum-based DNA damage
02

Mechanism of action

Formation of covalent platinum-DNA adducts (intrastrand and interstrand crosslinks) - Induction of bulky lesions that distort the DNA helix and block replication/transcription machinery[1][3][6] - Activation of cellular apoptosis pathways due to irreparable DNA damage[2][3]

03

Biological functions

Cell cycle arrestApoptosisInhibition of DNA replicationInhibition of transcriptionInduction of cell death
04

Disease associations

Cancer
05

Safety considerations

Nephrotoxicity (kidney toxicity)Neurotoxicity (nerve toxicity/peripheral neuropathy)Ototoxicity (hearing loss)MyelosuppressionDrug resistance due to enhanced DNA repair mechanisms
06

Interacting drugs

Cisplatin

2 more in the full profile.

07

Biomarkers

ERCC1 (excision repair cross-complementation group 1)BRCA1 (breast cancer type 1 susceptibility protein)

Beyond the preview

Go deeper on DNA crosslinking and damage induction via platinum adduct (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA crosslinking and damage induction via platinum adduct (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call